In TRIUMPH-3, retatrutide meaningfully reduced certain cardiovascular risk factors, with the highest dose delivering average reductions of 37.0% in triglycerides, 16.5% in non-HDL cholesterol, 9.3 mmHg in systolic blood pressure, 7.5 in (19.0 cm) in waist circumference, and 51.2% in high-sensitivity C-reactive protein (hsCRP)
and renal clearance, which removes both intact and cleaved peptide from circulation
Medication users need regular followups, lab checks, and dose adjustments
Related Article: Best Sleep Aids How do you know if you are depleted of Glutathione
Each person responds differently to semaglutide treatment
Nourish: Eat a balanced breakfast with healthy fats to keep your energy stable